TherapeuticsMD Inc logo

TXMD - TherapeuticsMD Inc News Story

$0.305 -0.0  -2.7%

Last Trade - 9:00pm

Sector
Healthcare
Size
Small Cap
Market Cap £98.3m
Enterprise Value £158.7m
Revenue £67.0m
Position in Universe 5174th / 7405

TherapeuticsMD Inc expected to post a loss of 12  cents a share - Earnings Preview

Tue 4th May, 2021 2:39pm
* TherapeuticsMD Inc  TXMD.OQ   TXMD.O  is expected to show
a rise in quarterly revenue when it reports results on May 6.
* The Boca Raton, Florida-based company is expected to report  a
61.4% increase in revenue to $19.768 million from $12.25 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data.​​
​* Refinitiv's mean analyst estimate for TherapeuticsMD Inc is
for a loss of 12 cents per share. For the same quarter last
year, the company reported a loss of 21 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months.​
* Wall Street's median 12-month price target for TherapeuticsMD
Inc is $5.5​, about 79.1% above​ its last closing price
of $1.15. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.11       -0.10      -0.15     Missed  -42.9
 Sep. 30 2020  -0.14       -0.14      -0.12     Beat    12.2
 Jun. 30 2020  -0.17       -0.17      -0.19     Missed  -10.7​
 Mar. 31 2020  -0.19       -0.19      -0.21     Missed  -12
 Dec.          -0.19​      -0.19      -0.19     Met     -1.5​
 31​ 2019​                                              
 Sep. 30 2019  -0.19       -0.19      -0.13     Beat    32.2​
 Jun. 30 2019  -0.17       -0.17      -0.19     Missed  -10.2
 Mar. 31 2019  -0.16       -0.17      -0.16     Beat    4
 This summary was machine generated May 4 at 13:39 GMT.  All
figures in US dollars unless otherwise stated
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.